PHAR (Pharming Group NV) Sof foyda

PHAR (Pharming Group) - kompaniyaning tovar belgisi

GURU.Markets platformasidagi ushbu kunlik narxlar grafigi noyob immun patologiyalari uchun unikal terapiyalarni ishlab chiqadigan va raqobatchi yo'qligi sababli yuqori daromad keltiradigan Pharming Group N.V. (PHAR) faoliyatini namoyish etadi. Jori ko'rsatkich 0.02 darajasida bo'lib, u kompaniyaning asosiy dori vositalarining global bozorga kengayishi bilan qo'llab-quvvatlanmoqda. Kompaniyaning kapitali irsiy angioedemaga chalingan bemorlarning butun umr davomida davolanishi uchun sug'urta to'lovlari orqali shakllantirilgan.

PHAR (Pharming Group N.V.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

Pharming Group (PHAR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Pharming Corp|PHAR - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Pharming Corp|PHAR - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Pharming Group|PHAR - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi pharming.com|PHAR - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Pharming Group N.V.|PHAR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|PHAR - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pharming Corp|PHAR - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Pharming Group|Shoshilinch likvidlik pharming.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PHAR - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Pharming Group N.V.
Pharming asosiy tovari

Investorlar pul oqimlarini bozor kapitalizatsiyasi bilan solishtirish orqali emitentning ishonchliligini tekshiradilar. Ushbu metrika fundamental tendentsiyani tebranishlardan ajratgan holda, AQSh bozoridagi kunlik sof foydani o'lchaydi. Pharming Group N.V. (PHAR) konsolidatsiyalangan daromadlarini tahlil qilish orqali joriy rentabellik uchun haddan tashqari ko'p to'lov qilish xavfini baholash mumkin. Ushbu ko'rsatkichning o'sishi Pharming Group N.V. (PHAR) dagi butylash liniyalarining robotlashtirilishi va bioreaktor avtomatizatsiyasining samaradorligini tasdiqlaydi. Ushbu grafikning barqaror trayektoriyasi dori ishlab chiqarishning muvaffaqiyatli kengayganini ko'rsatadi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Soliqdan keyingi foyda NKTR|UPB: Sof foyda|zenasbio.com - Yakuniy foyda|IMNM (Immunome) - Sof foyda|Sof foyda Gossamer Bio Inc|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|SEPN (Septerna Pharma) - Yakuniy foyda|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA - Sof daromad|Rigel Pharmaceuticals, Inc. - Sof foyda|Sof moliyaviy natija AnaptysBio Inc ANAB|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|Kompaniya foydasi ENGN|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|JBIO - Yillik sof foyda|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Yillik sof foyda Cabaletta Bio Inc|VTYX - Kompaniyaning sof foydasi|Yakuniy foyda THTX (theratech.com)|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Sof daromad AGEN|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Adagene Inc. - Sof daromad|Yakuniy foyda IMA|STTK - Kompaniyaning sof foydasi|EQ (Equillium, Inc.) - Kompaniya foydasi|CNTB (connectbiopharm.com) - Sof daromad|IMUX - Sof moliyaviy natija|Sof daromad ATRA|Kompaniyaning sof foydasi IFRX|Sof daromad XFOR (X4 Pharma)|Sof moliyaviy natija adicetbio.com|Kompaniyaning sof foydasi Celularity CELU|INMB (inmunebio.com) - Soliqdan keyingi foyda|Barinthus Biotherapeutics plc - Sof foyda|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA: Soliqdan keyingi foyda|Sof foyda IBIO (iBio Corp)|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Vyome Holdings - Sof daromad|Yakuniy foyda REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda